BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Neomycin

Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis.

298+ PubMed studies analyzed · 6 RCTs · Evidence Score: 39.7

Research Domains

Neomycin has been studied across 20 research domains including 🦴 Bone & Joint, 🦠 Gut & Microbiome, 🧠 Focus & Attention, 🔥 Metabolic, ✨ Skin & Hair. The primary research focus is 🦴 Bone & Joint with 7% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Neomycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bufo
2 shared targets
mylabris
2 shared targets
dendrobium
2 shared targets
gentiana
2 shared targets
lycopus
2 shared targets
lithospermum
2 shared targets
Rubia
2 shared targets
taxillus
2 shared targets
alisma
2 shared targets
allium
2 shared targets
Loading evidence profile...

This evidence profile for Neomycin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.